Wednesday, June 10, 2026

pharma · Relapsing-Remitting Multiple Sclerosis · Spinal Muscular Atrophy

Biogen

Biogen is a pharma organization headquartered in VISAKHAPATNAM, IN. Primary therapeutic focus areas include Relapsing-Remitting Multiple Sclerosis, Spinal Muscular Atrophy, systemic lupus erythematosus, IgA nephropathy,

225 Binney Street, Cambridge, MA 02142, US HQ
7,534 Employees
NMPA registrant Type
Company details
Clinical program

BIIB115

Phase 1 · small molecule · Healthy Volunteer

BIIB115 for Healthy Volunteer is a Phase 1 program (small_molecule) at Biogen with 1 ClinicalTrials.gov record(s).

← All Biogen projects Phase 1 small molecule active

Internal code 277HV101

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Biogen
Phase
Phase 1
Modality
small_molecule
Indication
Healthy Volunteer
Status
active
Trials
1

Clinical trials